Some drug reps are creating confusion about changes to the Zocor (simvastatin) package insert
Some drug reps are creating confusion about changes to the Zocor (simvastatin) package insert.
New Zocor labeling contains more info about the risk of myopathy and rhabdomyolysis.
For example, the new labeling says not to exceed 20 mg/day of Zocor in patients taking amiodarone or verapamil.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote